IRIS
ROTI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.416
AS - Asia 5.287
EU - Europa 3.659
SA - Sud America 719
AF - Africa 272
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.364
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.246
SG - Singapore 1.836
CN - Cina 1.340
IT - Italia 1.179
VN - Vietnam 873
BR - Brasile 542
IE - Irlanda 491
HK - Hong Kong 408
SE - Svezia 364
DE - Germania 344
BD - Bangladesh 243
FR - Francia 242
FI - Finlandia 189
NL - Olanda 188
ZA - Sudafrica 170
UA - Ucraina 153
GB - Regno Unito 128
IN - India 115
TR - Turchia 112
RU - Federazione Russa 107
AT - Austria 102
CA - Canada 101
AR - Argentina 67
JP - Giappone 49
IQ - Iraq 44
MX - Messico 39
PH - Filippine 38
KR - Corea 32
PL - Polonia 32
CI - Costa d'Avorio 31
EC - Ecuador 27
BE - Belgio 25
ES - Italia 25
PK - Pakistan 25
ID - Indonesia 24
CO - Colombia 22
TH - Thailandia 20
UZ - Uzbekistan 18
VE - Venezuela 18
CZ - Repubblica Ceca 17
LT - Lituania 16
EG - Egitto 13
TW - Taiwan 13
IR - Iran 12
PY - Paraguay 12
SA - Arabia Saudita 12
TN - Tunisia 12
CL - Cile 11
KE - Kenya 11
MA - Marocco 11
UY - Uruguay 10
DZ - Algeria 9
JM - Giamaica 9
AU - Australia 8
NP - Nepal 8
AZ - Azerbaigian 7
IL - Israele 7
JO - Giordania 7
KZ - Kazakistan 7
PA - Panama 7
RO - Romania 7
PE - Perù 6
CH - Svizzera 5
ET - Etiopia 5
KG - Kirghizistan 5
LU - Lussemburgo 5
MY - Malesia 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
GR - Grecia 4
HR - Croazia 4
HU - Ungheria 4
LB - Libano 4
OM - Oman 4
SY - Repubblica araba siriana 4
AL - Albania 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
MD - Moldavia 3
PT - Portogallo 3
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
KH - Cambogia 2
KW - Kuwait 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
Totale 15.348
Salva come PNG Salva come JPEG
Città #
Singapore 952
Ashburn 765
San Jose 566
Dublin 491
Dallas 485
Chandler 472
Hong Kong 389
Parma 303
Beijing 294
Santa Clara 284
Ho Chi Minh City 257
Boardman 241
Hanoi 195
Johannesburg 160
Jacksonville 135
Ann Arbor 126
Lauterbourg 124
New York 120
Los Angeles 118
Dearborn 107
Munich 100
Princeton 90
Milan 87
Vienna 86
Nanjing 85
Shanghai 81
Bologna 74
Izmir 72
Hefei 70
Wilmington 62
Helsinki 56
São Paulo 55
Buffalo 53
Grafing 53
Shenyang 51
San Mateo 50
Marseille 49
Jinan 44
Toronto 44
Nanchang 43
Moscow 42
Chicago 40
Haiphong 39
Columbus 37
Da Nang 37
Rome 34
Seattle 33
Turku 33
Hebei 32
Montreal 32
Abidjan 31
Amsterdam 29
Tokyo 29
Frankfurt am Main 28
Guangzhou 28
Reggio Emilia 27
Modena 26
Tianjin 26
Verona 26
Changsha 25
Council Bluffs 25
Nuremberg 25
London 24
The Dalles 23
Des Moines 22
Kunming 22
Seoul 22
Warsaw 22
Atlanta 21
Brescia 21
Brussels 21
Rio de Janeiro 21
Brooklyn 20
Houston 20
Pune 20
Baghdad 19
Poplar 19
Denver 18
Bremen 17
Orem 17
Fremont 16
Hải Dương 16
Jiaxing 16
Phoenix 16
Brasília 15
Florence 15
Jakarta 15
San Francisco 15
Tashkent 15
Bengaluru 14
Biên Hòa 14
Perugia 14
West Jordan 14
Norwalk 13
Zhengzhou 13
Belo Horizonte 12
Brno 12
Chennai 12
Düsseldorf 12
Lahore 12
Totale 9.223
Salva come PNG Salva come JPEG
Nome #
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 256
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line 251
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors 238
Morphological, clinical, and molecular profiling of post-polycythemia vera accelerated/blast phase occurring with and without antecedent secondary myelofibrosis 229
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 228
1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients 218
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 213
227P Sexual dimorphism in immune profile of early and advanced NSCLC 202
Longitudinal Changes of CT-radiomic and Systemic Inflammatory Features Predict Survival in Advanced Non–Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors 197
Targeting oncogenic Notch signaling with SERCA inhibitors 187
Impact of the rs1024611 polymorphism of ccl2 on the pathophysiology and outcome of primary myelofibrosis 187
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS 184
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 178
Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 176
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients 174
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 173
Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia 170
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 166
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 162
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 157
Angiopoietins expression by human myeloma cells 156
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 156
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders 155
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 153
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 152
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 151
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes 148
Targeting Notch Trafficking and Processing in Cancers 147
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 145
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 144
IL-7 is induced by IL-6 in human myeloma cells: role in multiple myeloma 144
BCR/ABL fusion gene is detected in chronic myeloid leukemia endothelial cells 144
P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 142
Acute lymphoblastic leukaemia in Noonan syndrome. 141
Longitudinal blood immune-inflammatory and radiomic profiling to decode different patterns acquired resistance to immunotherapy in patients with NSCLC 139
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 138
THERAPEUTIC TARGETING OF NOTCH SIGNALING PATHWAY IN HEMATOLOGICAL MALIGNANCIES 136
Acute lymphoblastic leukaemia 135
SERCA MODULATION COUNTERACTS GLUCOCORTICOID RESISTANCE IN T-ALL 135
Human myeloma cells produce angiopoietin-1 but not angiopoietin-2: potential relationship with myeloma-induced angiogenesis 135
14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia 134
Venetoclax and bortezomib in relapsed/refractory early t-cell precursor acute lymphoblastic leukemia 133
MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia 132
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 131
The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia 130
BCR/ABL fusion gene is detected in chronic myeloid leukemia endothelial cells 130
SELECTIVE BLOCKADE OF ONCOGENIC NOTCH1 WITH THE NEW SERCA INHIBITOR CAD204520 129
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 129
Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia 129
A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome 127
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro 126
CD26 is differentially expressed throughout the life cycle of infantile hemangiomas and characterizes the proliferative phase 126
Activating somatic and germline TERT promoter variants in myeloid malignancies 124
Down-Modulation of Erk Protein Kinase Activity Inhibits Vascular Endothelial Growth Factor (VEGF) Secretion by human Myeloma Cell Lines 121
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 120
Haploidentical hematopoietic stem cell transplantation in adults using the αβTCR/CD19-based depletion of G-CSF-mobilized peripheral blood progenitor cells 120
Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia 118
IL-7 is produced by myeloma cells in presence of IL-6 118
Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic Leukemia 117
VASCULAR ENDOTHELIAL GROWTH FACTOR SECRETION BY MYELOMA CELLS IS INHIBITED BY DOWN-MODULATING ERK PROTEIN KINASE ACTIVITY 116
Osteopontin is produced by human multiple myeloma cells 116
Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling 116
Multiple myeloma patient with unusual extramedullary involvement 114
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 112
Down-modulation of ERK protein kinase activity suppresses human myeloma cell proliferation and myeloma-induced angiogenesis by VEGF inhibition 111
Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia. 110
Multiple myeloma patient with unusual extramedullary involvement 108
A distinct epigenetic program underlies the 1;7 translocation in myelodysplastic syndromes 108
Multiple Myeloma patient with unusual extramedullary involvement 107
Paracrine rather than autocrine basic FGF (bFGF) loop in multiple myeloma 107
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines 107
Chemical Genomic Screen Identifies Ionophores as Modulators of Notch1 in T-ALL 107
Nivolumab-Induced Guillain-Barré Syndrome Coupled With Remarkable Disease Response in a Case of Heavily Pretreated Lung Adenocarcinoma 106
WO/2016/073708 106
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 106
Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia 105
Bilateral tonsillar infiltration of T-cell prolymphocytic leukemia 105
IL-7 is produced by myeloma cells in presence of IL-6 102
Paracrine rather than autocrine basic FGF (bFGF) loop in multiple myeloma 100
Genetic and proteomic approaches to identify cancer drug targets. 100
Bone marrow endothelial cells carry BCR/ABL fusion gene from chronic myeloid leukemia patients. 100
Synergistic drug combinations with a CDK4/6 inhibitor in T-cell acute lymphoblastic leukemia 100
Human myeloma cells express IL-7 mRNA and secrete IL-7 in presence of IL-6 99
T(10;11)(P13;P14-21) PICALM-MLLT10 ACUTE LEUKEMIA: CHARACTERIZATION OF TWO CASES WITH DIFFERENT PHENOTYPIC PRESENTATION 98
FROM GENOMICS TO CHEMOGEGNOMICS IN T CELL ACUTE LYMPHOBLASTIC LEUKEMIA 95
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: From current standards to precision medicine 94
Leukemia-specific delivery of mutant NOT CH1 targeted therapy 94
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin 94
Genetic profile of acute lymphoblastic leukemia in a patient with the noonan syndrome 93
Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer. 89
Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy with Thyroid Carcinoma Cells: Novel Translational Insights 88
Differentially regulated high-throughput CT imaging features correlate to distinct tumor immune contextures portraying a radiomic signature with prognostic impact on surgically resected NSCLC 88
Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors. 87
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 87
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia. 85
e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia 85
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines. 84
New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma 82
Targeting the Activating Mutations of NOTCH1 in T-Cell Lymphoblastic Leukemia with a New SERCA Inhibitor CAD204520 81
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma 80
Totale 13.308
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.599
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 0 0 25
2021/2022517 16 16 11 15 7 64 72 55 27 40 32 162
2022/20231.922 219 191 106 124 206 206 32 117 585 7 82 47
2023/2024987 50 64 29 41 85 184 124 80 40 72 72 146
2024/20253.056 90 164 215 235 337 246 145 137 350 251 275 611
2025/20267.322 582 537 1.006 669 936 440 688 322 976 585 356 225
Totale 15.565